Docusate sodium is technically classified as a laxative, specifically a “stool softener” or “surfactant laxative.” It’s sold over the counter under brand names like Colace and is one of the most commonly recommended options for occasional constipation. However, the clinical evidence behind it tells a more complicated story than its popularity might suggest.
How Docusate Sodium Is Supposed to Work
Unlike stimulant laxatives that trigger muscle contractions in your intestines, docusate works as a surfactant. Think of it like a detergent: it’s designed to help water and fats mix into your stool, theoretically making it softer and easier to pass. This is why it’s categorized separately from other laxatives and often labeled simply as a “stool softener.”
When it does produce a result, it typically takes 12 to 72 hours to help produce a bowel movement. That’s considerably slower than stimulant laxatives, which often work within 6 to 12 hours. The trade-off is supposed to be gentleness: fewer cramps, less urgency, and a more natural-feeling bowel movement.
The Evidence Problem
Here’s what most people don’t realize: docusate sodium may not actually work better than a sugar pill. A comprehensive review published in The American Journal of Gastroenterology examined seven randomized, placebo-controlled studies spanning from 1956 to 2021. None of the seven studies found a significant difference between docusate (at doses of 100 to 400 mg per day) and placebo for softening stool in people with constipation.
An eighth study tested the very mechanism docusate is supposed to rely on: increasing the water content of stool. In that trial, 170 patients with chronic constipation took either docusate sodium (200 mg per day) or psyllium fiber (10.2 g per day) for two weeks. Docusate had no significant effect on stool water content. Stool remained below 72% water throughout the treatment period, a threshold that corresponds to hard stool. Psyllium, by contrast, did increase stool water content.
This lack of evidence has not gone unnoticed by professional organizations. The American College of Gastroenterology’s prior guidelines noted that small trials showed docusate was no better than placebo and inferior to psyllium. Their most recent clinical practice guideline on chronic constipation didn’t even include a recommendation for docusate, noting that properly designed trials are still needed to clarify whether it actually improves stool frequency or consistency.
Why It’s Still So Widely Used
Despite the weak evidence, docusate sodium remains one of the most frequently recommended stool softeners in hospitals and by primary care providers. Part of this is inertia: it’s been on the market for decades, it’s inexpensive, and it has very few side effects. It’s also perceived as gentle, which makes clinicians comfortable suggesting it after surgery or during pregnancy, situations where straining could be harmful.
The gap between clinical evidence and real-world use is wide. Many people take docusate and feel it helps them, which may reflect a placebo effect, natural variation in bowel habits, or the fact that they’re also drinking more water when they take it (the liquid form is recommended with 6 to 8 ounces of fluid).
Alternatives With Stronger Evidence
If you’re looking for a stool softening effect, psyllium fiber (sold as Metamucil and similar products) has direct evidence showing it increases stool water content, something docusate failed to do in head-to-head comparison. Psyllium forms a gel that holds water in the stool, making it softer and bulkier.
Osmotic laxatives like polyethylene glycol (MiraLAX) draw water into the intestines and have robust clinical trial data supporting their use for chronic constipation. Stimulant laxatives work faster but are generally reserved for short-term or occasional use.
Safety During Pregnancy and Breastfeeding
Docusate is occasionally used during pregnancy, and there’s no evidence it harms the baby. That said, other laxatives are typically tried first simply because more safety data exists for them. If you’re breastfeeding, only a tiny amount is expected to pass into breast milk, and it’s unlikely to affect your baby. There’s also no evidence that docusate affects fertility in either men or women.
For most people, docusate sodium is very well tolerated. Side effects are uncommon and generally mild. The bigger question isn’t whether it’s safe, but whether it’s doing anything meaningful beyond what a glass of water and some dietary fiber could accomplish on their own.